Shares

8 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2023

Feb 09, 2024

BUY
$49.38 - $63.75 $12,493 - $16,128
253 New
253 $15,000
Q4 2022

Feb 13, 2023

BUY
$59.56 - $76.6 $15,068 - $19,379
253 New
253 $15,000
Q3 2021

Nov 05, 2021

SELL
$59.21 - $78.66 $7,045 - $9,360
-119 Closed
0 $0
Q2 2021

Aug 12, 2021

BUY
$51.39 - $66.9 $6,115 - $7,961
119 New
119 $8,000
Q1 2021

May 24, 2021

SELL
$49.14 - $59.89 $5,847 - $7,126
-119 Closed
0 $0
Q3 2020

Nov 16, 2020

BUY
$35.33 - $51.04 $4,204 - $6,073
119 New
119 $6,000
Q2 2020

Aug 10, 2020

SELL
$22.91 - $39.83 $2,726 - $4,739
-119 Closed
0 $0
Q2 2019

Aug 01, 2019

BUY
$18.54 - $40.97 $2,206 - $4,875
119 New
119 $0

Others Institutions Holding AXNX

About Axonics, Inc.


  • Ticker AXNX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 49,123,600
  • Market Cap $3.49B
  • Description
  • Axonics, Inc., a medical technology company, engages in the development and commercialization of sacral neuromodulation (SNM) systems. The company's SNM systems are used to treat patients with overactive bladder, including urinary urge incontinence and urinary urgency frequency, as well as fecal incontinence and non-obstructive urinary retention...
More about AXNX
Track This Portfolio

Track Advisory Services Network, LLC Portfolio

Follow Advisory Services Network, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Advisory Services Network, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Advisory Services Network, LLC with notifications on news.